文献速递血栓与止血

FcRn增强含IgG免疫复合物诱导组织因子活性

FcRn augments induction of tissue factor activity by IgG-containing immune complexes.
PubMed 文献 · Blood · 2020-01-01

本研究探讨新生儿Fc受体(FcRn)是否参与含IgG免疫复合物(ICs)诱导单核细胞组织因子(TF)依赖性因子Xa(FXa)活性。使用THP-1单核细胞和人单核细胞,发现阻断IgG与FcRn结合的人源化单克隆抗体可抑制来自肝素诱导血小板减少症(HIT)、抗磷脂综合征及抗Rh(D)抗体介导溶血等相关ICs诱导的FXa活性;Fc工程化不能结合FcRn的ICs不诱导FXa活性;在表达人FcγRIIa的HIT小鼠模型中,输注抗FcRn单抗可预防微血管损伤后纤维蛋白沉积。

要点

  • FcRn参与含IgG免疫复合物诱导的单核细胞TF依赖性FXa活性。
  • 阻断IgG与FcRn结合可抑制HIT、抗磷脂综合征及抗Rh(D)相关ICs的FXa活性。
  • 抗FcRn单抗在HIT小鼠模型中预防微血管损伤后纤维蛋白沉积。

核心结论

  • FcRn参与可溶性和细胞相关含IgG免疫复合物诱导的TF依赖性FXa活性。

研究设计与样本

  • 实验研究使用THP-1单核细胞和人单核细胞,以及表达人FcγRIIa转基因的HIT小鼠模型。

主要发现

  • 阻断IgG与FcRn结合的人源化单克隆抗体抑制了含IgG的ICs诱导的FXa活性。
  • 能结合FcγR和FcRn的含IgG ICs诱导FXa活性,而Fc工程化不能结合FcRn的ICs不诱导。
  • 在HIT小鼠模型中,输注抗FcRn单抗预防了微血管损伤后的纤维蛋白沉积。

临床怎么用

  • 抗FcRn抗体可能降低含IgG免疫复合物相关疾病中的静脉血栓栓塞风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Thromboembolism complicates disorders caused by immunoglobulin G (IgG)-containing immune complexes (ICs), but the underlying mechanisms are incompletely understood. Prior evidence indicates that induction of tissue factor (TF) on monocytes, a pivotal step in the initiation, localization, and propagation of coagulation by ICs, is mediated through Fcγ receptor IIa (FcγRIIa); however, the involvement of other receptors has not been investigated in detail. The neonatal Fc receptor (FcRn) that mediates IgG and albumin recycling also participates in cellular responses to IgG-containing ICs. Here we asked whether FcRn is also involved in the induction of TF-dependent factor Xa (FXa) activity by IgG-containing ICs by THP-1 monocytic cells and human monocytes. Induction of FXa activity by ICs containing IgG antibodies to platelet factor 4 (PF4) involved in heparin-induced thrombocytopenia (HIT), β-2-glycoprotein-1 implicated in antiphospholipid syndrome, or red blood cells coated with anti-(α)-Rh(D) antibodies that mediate hemolysis in vivo was inhibited by a humanized monoclonal antibody (mAb) that blocks IgG binding to human FcRn. IgG-containing ICs that bind to FcγR and FcRn induced FXa activity, whereas IgG-containing ICs with an Fc engineered to be unable to engage FcRn did not. Infusion of an α-FcRn mAb prevented fibrin deposition after microvascular injury in a murine model of HIT in which human FcγRIIa was expressed as a transgene. These data implicate FcRn in TF-dependent FXa activity induced by soluble and cell-associated IgG-containing ICs. Antibodies to FcRn, now in clinical trials in warm autoimmune hemolytic anemia to lower IgG antibodies and IgG containing ICs may also reduce the risk of venous thromboembolism.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Cines DB, Zaitsev S, Rauova L, et al. FcRn augments induction of tissue factor activity by IgG-containing immune complexes. Blood. 2020. PMID: 32187355. doi:10.1182/blood.2019001133

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。